Your browser doesn't support javascript.
loading
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody.
Chandramouli, Sumana; Ciferri, Claudio; Nikitin, Pavel A; Caló, Stefano; Gerrein, Rachel; Balabanis, Kara; Monroe, James; Hebner, Christy; Lilja, Anders E; Settembre, Ethan C; Carfi, Andrea.
Afiliação
  • Chandramouli S; GSK Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
  • Ciferri C; GSK Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
  • Nikitin PA; Novartis Institutes for Biomedical Research, Emeryville, California 94608, USA.
  • Caló S; GSK Vaccines, Via Fiorentina 1, Siena 53100, Italy.
  • Gerrein R; GSK Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
  • Balabanis K; GSK Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
  • Monroe J; GSK Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
  • Hebner C; Novartis Institutes for Biomedical Research, Emeryville, California 94608, USA.
  • Lilja AE; GSK Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
  • Settembre EC; Novartis Influenza Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
  • Carfi A; GSK Vaccines, 45 Sidney Street, Cambridge, Massachusetts 02139, USA.
Nat Commun ; 6: 8176, 2015 Sep 14.
Article em En | MEDLINE | ID: mdl-26365435
ABSTRACT
Human cytomegalovirus (HCMV) poses a significant threat to immunocompromised individuals and neonates infected in utero. Glycoprotein B (gB), the herpesvirus fusion protein, is a target for neutralizing antibodies and a vaccine candidate due to its indispensable role in infection. Here we show the crystal structure of the HCMV gB ectodomain bound to the Fab fragment of 1G2, a neutralizing human monoclonal antibody isolated from a seropositive subject. The gB/1G2 interaction is dominated by aromatic residues in the 1G2 heavy chain CDR3 protruding into a hydrophobic cleft in the gB antigenic domain 5 (AD-5). Structural analysis and comparison with HSV gB suggest the location of additional neutralizing antibody binding sites on HCMV gB. Finally, immunoprecipitation experiments reveal that 1G2 can bind to HCMV virion gB suggesting that its epitope is exposed and accessible on the virus surface. Our data will support the development of vaccines and therapeutic antibodies against HCMV infection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos Fab das Imunoglobulinas / Proteínas do Envelope Viral / Proteínas Virais de Fusão / Anticorpos Neutralizantes / Anticorpos Antivirais / Antígenos Virais Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos Fab das Imunoglobulinas / Proteínas do Envelope Viral / Proteínas Virais de Fusão / Anticorpos Neutralizantes / Anticorpos Antivirais / Antígenos Virais Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos